Package 31722-753-32

{"route": ["ORAL"], "spl_id": "2b44b10b-132c-4593-e063-6294a90a3ffd", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["49d53e74-3798-4463-b817-1c8beb755034"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "600 TABLET, FILM COATED in 1 BOTTLE (31722-753-06)", "package_ndc": "31722-753-06", "marketing_start_date": "20140106"}, {"sample": false, "description": "10 TABLET, FILM COATED in 1 BLISTER PACK (31722-753-31)", "package_ndc": "31722-753-31", "marketing_start_date": "20140106"}, {"sample": false, "description": "100 TABLET, FILM COATED in 1 CARTON (31722-753-32)", "package_ndc": "31722-753-32", "marketing_start_date": "20140106"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-753-60)", "package_ndc": "31722-753-60", "marketing_start_date": "20140106"}], "brand_name": "Lamivudine", "product_id": "31722-753_2b44b10b-132c-4593-e063-6294a90a3ffd", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-753", "generic_name": "Lamivudine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA203277", "marketing_category": "ANDA", "marketing_start_date": "20140106", "listing_expiration_date": "20261231"}